Combating antimicrobial resistance: a paradigm shift from general to precision medicine

  11 April 2024

Antimicrobial resistance (AMR) is a global health threat due to its various mechanisms, making treatment difficult. Precision medicine, focusing on individualized treatment for patients’ specific genetic makeup, offers a paradigm shift in addressing AMR challenges. Bacteriophages and antimicrobial peptides (AMPs) are potential alternatives to antibiotics, offering targeted therapy and broad-spectrum antimicrobial activity. Despite challenges like limited host range and regulatory concerns, bacteriophages have proven effective against infections. AMPs, with their low molecular weight and broad-spectrum activity, can serve as a first line of defense against antibiotic-resistant bacteria.

Further reading: Chemical Biology Letters
Author(s): Firuj Ahmed et al
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed